BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3014912)

  • 1. Histologic variation in the skin lesions of the glucagonoma syndrome.
    Kheir SM; Omura EF; Grizzle WE; Herrera GA; Lee I
    Am J Surg Pathol; 1986 Jul; 10(7):445-53. PubMed ID: 3014912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glucagonoma syndrome with normal blood glucagon ].
    Quencez E; Zultak M; Blanc D; Gillet M; Laurent R
    Ann Dermatol Venereol; 1987; 114(9):1103-8. PubMed ID: 2829690
    [No Abstract]   [Full Text] [Related]  

  • 3. A postmortem study of malignant glucagonoma with heart muscle hypertrophy, including chemical, histochemical, immunohistological and ultrastructural observations.
    Takemiya M; Miyayama H; Takeya M; Takeuchi T; Konno T; Kitoh M; Fukushima H
    Hum Pathol; 1981 Nov; 12(11):988-99. PubMed ID: 6274784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucagonoma syndrome].
    Tellechea O; Baptista AP
    Acta Med Port; 1988; 1(2):149-52. PubMed ID: 2849866
    [No Abstract]   [Full Text] [Related]  

  • 6. Glucagonoma syndrome. A clinicopathologic, immunocytochemical, and ultrastructural study.
    Vandersteen PR; Scheithauer BW
    J Am Acad Dermatol; 1985 Jun; 12(6):1032-9. PubMed ID: 2989344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagonoma syndrome: case report and literature review.
    Parker CM; Hanke CW; Madura JA; Liss EC
    J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The glucagonoma syndrome].
    Rappersberger K; Wolff-Schreiner E; Konrad K; Wolff K
    Hautarzt; 1987 Oct; 38(10):589-98. PubMed ID: 2824404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glucagonoma syndrome.
    Shupack JL; Berczeller PH; Stevens DM
    J Dermatol Surg Oncol; 1978 Mar; 4(3):242-7. PubMed ID: 204668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hyperplasia of the glucagon-producing cells of the pancreas (the glucagonoma syndrome)].
    Saenko VF; Belianskiĭ LS; Dubitskiĭ AE; Cherviak PI; Furmanenko ED
    Klin Khir (1962); 1988; (11):60. PubMed ID: 2851685
    [No Abstract]   [Full Text] [Related]  

  • 11. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagonoma syndrome demonstrating giant duodenal villi.
    Stevens FM; Flanagan RW; O'Gorman D; Buchanan KD
    Gut; 1984 Jul; 25(7):784-91. PubMed ID: 6329923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glucagonoma syndrome].
    Baptista AP; Tellechea O; Aguiar M; Leitão A
    Acta Med Port; 1988; 1(2):141-4. PubMed ID: 2849865
    [No Abstract]   [Full Text] [Related]  

  • 14. The glucagonoma syndrome--report of a case without overt diabetes.
    Leibovici V; Granot E; Eid A; Goldin E; Okon E
    J Dermatol; 1987 Oct; 14(5):491-6. PubMed ID: 2830323
    [No Abstract]   [Full Text] [Related]  

  • 15. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
    Chaw L; Krop TM; Hood AF
    Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucagonoma tumors and syndrome.
    Montenegro-Rodas F; Samaan NA
    Curr Probl Cancer; 1981 Dec; 6(6):1-54. PubMed ID: 6276079
    [No Abstract]   [Full Text] [Related]  

  • 17. Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.
    Toberer F; Hartschuh W; Wiedemeyer K
    Am J Dermatopathol; 2019 Mar; 41(3):e29-e32. PubMed ID: 30124507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Iatrogenic glucagonoma syndrome?].
    Benhamou PY; Reymond JL; Boizel R; Béani JC; Amblard P
    Ann Dermatol Venereol; 1988; 115(6-7):717-9. PubMed ID: 2849361
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
    Pedersen NB; Jonsson L; Holst JJ
    Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.